316,INMB,INmune Bio Inc.,https://www.nasdaq.com/market-activity/stocks/INMB/news-headlines
318,INO,Inovio Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/INO/news-headlines
319,INSM,Insmed Inc.,https://www.nasdaq.com/market-activity/stocks/INSM/news-headlines
320,INVA,Innoviva Inc.,https://www.nasdaq.com/market-activity/stocks/INVA/news-headlines
321,INZY,Inozyme Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/INZY/news-headlines
322,IONS,Ionis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/IONS/news-headlines
323,IOVA,Iovance Biotherapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/IOVA/news-headlines
324,IPHA,Innate Pharma S.A.,https://www.nasdaq.com/market-activity/stocks/IPHA/news-headlines
325,IRWD,Ironwood Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/IRWD/news-headlines
326,ISEE,IVERIC bio Inc.,https://www.nasdaq.com/market-activity/stocks/ISEE/news-headlines
327,ITCI,Intra-Cellular Therapies Inc.,https://www.nasdaq.com/market-activity/stocks/ITCI/news-headlines
328,ITOS,iTeos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ITOS/news-headlines
329,ITRM,Iterum Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/ITRM/news-headlines
330,IVA,Inventiva S.A.,https://www.nasdaq.com/market-activity/stocks/IVA/news-headlines
331,JAGX,Jaguar Health Inc.,https://www.nasdaq.com/market-activity/stocks/JAGX/news-headlines
332,JAZZ,Jazz Pharmaceuticals plc,https://www.nasdaq.com/market-activity/stocks/JAZZ/news-headlines
333,JNCE,Jounce Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/JNCE/news-headlines
334,JNJ,Johnson & Johnson,https://www.nasdaq.com/market-activity/stocks/JNJ/news-headlines
335,KALA,Kala Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/KALA/news-headlines
336,KALV,KalVista Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/KALV/news-headlines
337,KDMN,Kadmon Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/KDMN/news-headlines
338,KDNY,Chinook Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KDNY/news-headlines
339,KLDO,Kaleido Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/KLDO/news-headlines
340,KMDA,Kamada Ltd.,https://www.nasdaq.com/market-activity/stocks/KMDA/news-headlines
341,KMPH,KemPharm Inc,https://www.nasdaq.com/market-activity/stocks/KMPH/news-headlines
342,KNSA,Kiniksa Pharmaceuticals Ltd.,https://www.nasdaq.com/market-activity/stocks/KNSA/news-headlines
343,KOD,Kodiak Sciences Inc,https://www.nasdaq.com/market-activity/stocks/KOD/news-headlines
344,KPTI,Karyopharm Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KPTI/news-headlines
346,KRON,Kronos Bio Inc.,https://www.nasdaq.com/market-activity/stocks/KRON/news-headlines
347,KROS,Keros Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KROS/news-headlines
348,KRTX,Karuna Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KRTX/news-headlines
349,KRYS,Krystal Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/KRYS/news-headlines
350,KTOV,Kitov Pharma Ltd.,https://www.nasdaq.com/market-activity/stocks/KTOV/news-headlines
351,KTRA,Kintara Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KTRA/news-headlines
352,KURA,Kura Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/KURA/news-headlines
353,KYMR,Kymera Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KYMR/news-headlines
354,KZIA,Kazia Therapeutics Limited,https://www.nasdaq.com/market-activity/stocks/KZIA/news-headlines
355,KZR,Kezar Life Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/KZR/news-headlines
356,LCTX,"Lineage Cell Therapeutics, Inc.",https://www.nasdaq.com/market-activity/stocks/LCTX/news-headlines
357,LEGN,Legend Biotech Corporation,https://www.nasdaq.com/market-activity/stocks/LEGN/news-headlines
358,LGND,Ligand Pharmaceuticals Incorporated,https://www.nasdaq.com/market-activity/stocks/LGND/news-headlines
359,LIFE,aTyr Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/LIFE/news-headlines
360,LJPC,La Jolla Pharmaceutical Company,https://www.nasdaq.com/market-activity/stocks/LJPC/news-headlines
361,LLY,Eli Lilly and Company,https://www.nasdaq.com/market-activity/stocks/LLY/news-headlines
362,LNTH,Lantheus Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/LNTH/news-headlines
363,LOGC,LogicBio Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LOGC/news-headlines
364,LPCN,Lipocine Inc.,https://www.nasdaq.com/market-activity/stocks/LPCN/news-headlines
365,LPTX,Leap Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LPTX/news-headlines
366,LQDA,Liquidia Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/LQDA/news-headlines
367,LRMR,Larimar Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LRMR/news-headlines
368,LUMO,Lumos Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/LUMO/news-headlines
369,LXRX,Lexicon Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/LXRX/news-headlines
370,LYRA,Lyra Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LYRA/news-headlines
371,MACK,Merrimack Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MACK/news-headlines
372,MBIO,Mustang Bio Inc.,https://www.nasdaq.com/market-activity/stocks/MBIO/news-headlines
373,MBRX,Moleculin Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/MBRX/news-headlines
374,MCRB,Seres Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MCRB/news-headlines
375,MDGL,Madrigal Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MDGL/news-headlines
376,MDWD,MediWound Ltd.,https://www.nasdaq.com/market-activity/stocks/MDWD/news-headlines
377,MEIP,MEI Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/MEIP/news-headlines
378,MESO,Mesoblast Limited,https://www.nasdaq.com/market-activity/stocks/MESO/news-headlines
379,MGEN,Miragen Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MGEN/news-headlines
380,MGNX,MacroGenics Inc.,https://www.nasdaq.com/market-activity/stocks/MGNX/news-headlines
381,MGTA,Magenta Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MGTA/news-headlines
382,MGTX,MeiraGTx Holdings plc,https://www.nasdaq.com/market-activity/stocks/MGTX/news-headlines
383,MIRM,Mirum Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MIRM/news-headlines
384,MIST,Milestone Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MIST/news-headlines
385,MITO,Stealth BioTherapeutics Corp.,https://www.nasdaq.com/market-activity/stocks/MITO/news-headlines
386,MLND,Millendo Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MLND/news-headlines
387,MNK,Mallinckrodt plc,https://www.nasdaq.com/market-activity/stocks/MNK/news-headlines
388,MNKD,MannKind Corporation,https://www.nasdaq.com/market-activity/stocks/MNKD/news-headlines
389,MNLO,VYNE Therapeutics,https://www.nasdaq.com/market-activity/stocks/MNLO/news-headlines
390,MNOV,MediciNova Inc.,https://www.nasdaq.com/market-activity/stocks/MNOV/news-headlines
391,MNPR,Monopar Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MNPR/news-headlines
392,MOR,MorphoSys AG,https://www.nasdaq.com/market-activity/stocks/MOR/news-headlines
393,MORF,Morphic Holding Inc.,https://www.nasdaq.com/market-activity/stocks/MORF/news-headlines
394,MREO,Mereo BioPharma Group plc,https://www.nasdaq.com/market-activity/stocks/MREO/news-headlines
395,MRK,Merck & Company Inc. (new),https://www.nasdaq.com/market-activity/stocks/MRK/news-headlines
396,MRKR,Marker Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MRKR/news-headlines
397,MRNA,Moderna Inc.,https://www.nasdaq.com/market-activity/stocks/MRNA/news-headlines
398,MRNS,Marinus Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MRNS/news-headlines
399,MRSN,Mersana Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MRSN/news-headlines
400,MRTX,Mirati Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MRTX/news-headlines
401,MRUS,Merus N.V.,https://www.nasdaq.com/market-activity/stocks/MRUS/news-headlines
402,MTCR,Metacrine Inc.,https://www.nasdaq.com/market-activity/stocks/MTCR/news-headlines
403,MTEM,Molecular Templates Inc.,https://www.nasdaq.com/market-activity/stocks/MTEM/news-headlines
404,MTNB,Matinas Biopharma Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/MTNB/news-headlines
405,MYL,Mylan N.V.,https://www.nasdaq.com/market-activity/stocks/MYL/news-headlines
406,MYOK,MyoKardia Inc.,https://www.nasdaq.com/market-activity/stocks/MYOK/news-headlines
407,MYOV,Myovant Sciences Ltd.,https://www.nasdaq.com/market-activity/stocks/MYOV/news-headlines
408,NAVB,Navidea Biopharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NAVB/news-headlines
409,NBIX,Neurocrine Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/NBIX/news-headlines
410,NBRV,Nabriva Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/NBRV/news-headlines
411,NBY,NovaBay Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NBY/news-headlines
412,NCNA,NuCana plc,https://www.nasdaq.com/market-activity/stocks/NCNA/news-headlines
413,NEOS,Neos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NEOS/news-headlines
414,NERV,Minerva Neurosciences Inc,https://www.nasdaq.com/market-activity/stocks/NERV/news-headlines
415,NGM,NGM Biopharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NGM/news-headlines
416,NK,NantKwest Inc.,https://www.nasdaq.com/market-activity/stocks/NK/news-headlines
417,NKTR,Nektar Therapeutics,https://www.nasdaq.com/market-activity/stocks/NKTR/news-headlines
418,NKTX,Nkarta Inc.,https://www.nasdaq.com/market-activity/stocks/NKTX/news-headlines
419,NLTX,Neoleukin Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NLTX/news-headlines
420,NMTR,9 Meters Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/NMTR/news-headlines
421,NNVC,NanoViricides Inc.,https://www.nasdaq.com/market-activity/stocks/NNVC/news-headlines
422,NOVN,Novan Inc.,https://www.nasdaq.com/market-activity/stocks/NOVN/news-headlines
423,NRBO,NeuroBo Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NRBO/news-headlines
424,NRIX,Nurix Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NRIX/news-headlines
425,NTEC,Intec Pharma Ltd.,https://www.nasdaq.com/market-activity/stocks/NTEC/news-headlines
426,NTLA,Intellia Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NTLA/news-headlines
427,NTRP,Neurotrope Inc.,https://www.nasdaq.com/market-activity/stocks/NTRP/news-headlines
428,NVAX,Novavax Inc.,https://www.nasdaq.com/market-activity/stocks/NVAX/news-headlines
429,NVCR,NovoCure Limited,https://www.nasdaq.com/market-activity/stocks/NVCR/news-headlines
430,NVIV,InVivo Therapeutics Holdings Corp.,https://www.nasdaq.com/market-activity/stocks/NVIV/news-headlines
431,NVO,Novo Nordisk A/S,https://www.nasdaq.com/market-activity/stocks/NVO/news-headlines
432,NVS,Novartis AG,https://www.nasdaq.com/market-activity/stocks/NVS/news-headlines
433,NVUS,Novus Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NVUS/news-headlines
435,NXTC,NextCure Inc.,https://www.nasdaq.com/market-activity/stocks/NXTC/news-headlines
436,NYMX,Nymox Pharmaceutical Corporation,https://www.nasdaq.com/market-activity/stocks/NYMX/news-headlines
437,OBSV,ObsEva SA,https://www.nasdaq.com/market-activity/stocks/OBSV/news-headlines
438,OCGN,"Ocugen, Inc.",https://www.nasdaq.com/market-activity/stocks/OCGN/news-headlines
439,OCUL,Ocular Therapeutix Inc.,https://www.nasdaq.com/market-activity/stocks/OCUL/news-headlines
440,ODT,Odonate Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ODT/news-headlines
441,OGEN,Oragenics Inc.,https://www.nasdaq.com/market-activity/stocks/OGEN/news-headlines
442,OMER,Omeros Corporation,https://www.nasdaq.com/market-activity/stocks/OMER/news-headlines
443,ONCR,Oncorus Inc.,https://www.nasdaq.com/market-activity/stocks/ONCR/news-headlines
444,ONCS,OncoSec Medical Incorporated,https://www.nasdaq.com/market-activity/stocks/ONCS/news-headlines
445,ONCT,Oncternal Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ONCT/news-headlines
446,ONCY,Oncolytics Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/ONCY/news-headlines
447,ONTX,Onconova Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ONTX/news-headlines
448,OPK,Opko Health Inc.,https://www.nasdaq.com/market-activity/stocks/OPK/news-headlines
449,OPNT,Opiant Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/OPNT/news-headlines
450,OPTN,OptiNose Inc.,https://www.nasdaq.com/market-activity/stocks/OPTN/news-headlines
451,ORIC,Oric Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ORIC/news-headlines
452,ORMP,Oramed Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ORMP/news-headlines
453,ORTX,Orchard Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/ORTX/news-headlines
454,OSMT,Osmotica Pharmaceuticals plc,https://www.nasdaq.com/market-activity/stocks/OSMT/news-headlines
455,OTIC,Otonomy Inc.,https://www.nasdaq.com/market-activity/stocks/OTIC/news-headlines
456,OTLK,Outlook Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/OTLK/news-headlines
457,OVID,Ovid Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/OVID/news-headlines
458,OYST,Oyster Point Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/OYST/news-headlines
459,PASG,Passage Bio Inc.,https://www.nasdaq.com/market-activity/stocks/PASG/news-headlines
460,PBYI,Puma Biotechnology Inc,https://www.nasdaq.com/market-activity/stocks/PBYI/news-headlines
461,PCRX,Pacira BioSciences Inc.,https://www.nasdaq.com/market-activity/stocks/PCRX/news-headlines
462,PCVX,Vaxcyte Inc.,https://www.nasdaq.com/market-activity/stocks/PCVX/news-headlines
463,PDSB,PDS Biotechnology Corporation,https://www.nasdaq.com/market-activity/stocks/PDSB/news-headlines
464,PFE,Pfizer Inc.,https://www.nasdaq.com/market-activity/stocks/PFE/news-headlines
466,PGEN,Precigen Inc.,https://www.nasdaq.com/market-activity/stocks/PGEN/news-headlines
467,PHAS,PhaseBio Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PHAS/news-headlines
468,PHAT,Phathom Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PHAT/news-headlines
469,PHIO,Phio Pharmaceuticals Corp.,https://www.nasdaq.com/market-activity/stocks/PHIO/news-headlines
470,PIRS,Pieris Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PIRS/news-headlines
471,PLRX,Pliant Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PLRX/news-headlines
472,PLUS,ePlus inc.,https://www.nasdaq.com/market-activity/stocks/PLUS/news-headlines
473,PLX,Protalix BioTherapeutics Inc. (DE),https://www.nasdaq.com/market-activity/stocks/PLX/news-headlines
474,PLXP,PLx Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/PLXP/news-headlines
477,PROG,Progenity Inc.,https://www.nasdaq.com/market-activity/stocks/PROG/news-headlines
478,PRQR,ProQR Therapeutics N.V.,https://www.nasdaq.com/market-activity/stocks/PRQR/news-headlines
479,PRTA,Prothena Corporation plc,https://www.nasdaq.com/market-activity/stocks/PRTA/news-headlines
480,PRTK,Paratek Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PRTK/news-headlines
481,PRVB,Provention Bio Inc.,https://www.nasdaq.com/market-activity/stocks/PRVB/news-headlines
482,PRVL,Prevail Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PRVL/news-headlines
483,PSNL,Personalis Inc.,https://www.nasdaq.com/market-activity/stocks/PSNL/news-headlines
484,PSTI,Pluristem Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PSTI/news-headlines
485,PSTV,PLUS THERAPEUTICS Inc.,https://www.nasdaq.com/market-activity/stocks/PSTV/news-headlines
486,PSTX,Poseida Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PSTX/news-headlines
487,PTCT,PTC Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PTCT/news-headlines
488,PTGX,Protagonist Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PTGX/news-headlines
489,PTI,Proteostasis Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PTI/news-headlines
490,PTN,Palatin Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/PTN/news-headlines
491,PULM,Pulmatrix Inc.,https://www.nasdaq.com/market-activity/stocks/PULM/news-headlines
492,PYPD,PolyPid Ltd.,https://www.nasdaq.com/market-activity/stocks/PYPD/news-headlines
493,QLGN,Qualigen Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/QLGN/news-headlines
494,QURE,uniQure N.V.,https://www.nasdaq.com/market-activity/stocks/QURE/news-headlines
495,RAPT,RAPT Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RAPT/news-headlines
496,RARE,Ultragenyx Pharmaceutical Inc.,https://www.nasdaq.com/market-activity/stocks/RARE/news-headlines
497,RCKT,Rocket Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RCKT/news-headlines
498,RCUS,Arcus Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/RCUS/news-headlines
499,RDHL,Redhill Biopharma Ltd.,https://www.nasdaq.com/market-activity/stocks/RDHL/news-headlines
500,RDUS,Radius Health Inc.,https://www.nasdaq.com/market-activity/stocks/RDUS/news-headlines
501,REGN,Regeneron Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/REGN/news-headlines
502,REPH,Recro Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/REPH/news-headlines
503,REPL,Replimune Group Inc.,https://www.nasdaq.com/market-activity/stocks/REPL/news-headlines
504,RETA,Reata Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RETA/news-headlines
505,REXN,Rexahn Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/REXN/news-headlines
506,RGEN,Repligen Corporation,https://www.nasdaq.com/market-activity/stocks/RGEN/news-headlines
507,RGLS,Regulus Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RGLS/news-headlines
508,RGNX,REGENXBIO Inc.,https://www.nasdaq.com/market-activity/stocks/RGNX/news-headlines
509,RHHBY,Roche Holding AG ADR,https://www.nasdaq.com/market-activity/stocks/RHHBY/news-headlines
510,RIGL,Rigel Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RIGL/news-headlines
511,RLAY,Relay Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RLAY/news-headlines
512,RLMD,Relmada Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RLMD/news-headlines
513,RMTI,Rockwell Medical Inc.,https://www.nasdaq.com/market-activity/stocks/RMTI/news-headlines
514,RNA,Avidity Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/RNA/news-headlines
515,RNLX,Renalytix AI plc,https://www.nasdaq.com/market-activity/stocks/RNLX/news-headlines
516,RPTX,Repare Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RPTX/news-headlines
517,RTRX,Retrophin Inc.,https://www.nasdaq.com/market-activity/stocks/RTRX/news-headlines
518,RUBY,Rubius Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RUBY/news-headlines
519,RVMD,Revolution Medicines Inc - Ordinary Shares,https://www.nasdaq.com/market-activity/stocks/RVMD/news-headlines
520,RVNC,Revance Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RVNC/news-headlines
521,RVVTF,Revive Therapeutics Ltd,https://www.nasdaq.com/market-activity/stocks/RVVTF/news-headlines
522,RYTM,Rhythm Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RYTM/news-headlines
523,SAGE,Sage Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SAGE/news-headlines
524,SAVA,Cassava Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/SAVA/news-headlines
525,SBBP,Strongbridge Biopharma plc,https://www.nasdaq.com/market-activity/stocks/SBBP/news-headlines
526,SBPH,Spring Bank Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SBPH/news-headlines
527,SCPH,scPharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SCPH/news-headlines
528,SCYX,SCYNEXIS Inc.,https://www.nasdaq.com/market-activity/stocks/SCYX/news-headlines
529,SEEL,Seelos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SEEL/news-headlines
530,SELB,Selecta Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/SELB/news-headlines
531,SESN,Sesen Bio Inc.,https://www.nasdaq.com/market-activity/stocks/SESN/news-headlines
532,SGEN,Seagen Inc Com,https://www.nasdaq.com/market-activity/stocks/SGEN/news-headlines
533,SGMO,Sangamo Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SGMO/news-headlines
534,SIGA,SIGA Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/SIGA/news-headlines
535,SLDB,Solid Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/SLDB/news-headlines
536,SLGL,Sol-Gel Technologies Ltd.,https://www.nasdaq.com/market-activity/stocks/SLGL/news-headlines
537,SLNO,Soleno Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SLNO/news-headlines
538,SLRX,Salarius Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SLRX/news-headlines
539,SLS,SELLAS Life Sciences Group Inc.,https://www.nasdaq.com/market-activity/stocks/SLS/news-headlines
540,SMMT,Summit Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SMMT/news-headlines
541,SNCA,Seneca Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/SNCA/news-headlines
542,SNDX,Syndax Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SNDX/news-headlines
543,SNGX,Soligenix Inc.,https://www.nasdaq.com/market-activity/stocks/SNGX/news-headlines
544,SNSS,Sunesis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SNSS/news-headlines
545,SNY,Sanofi,https://www.nasdaq.com/market-activity/stocks/SNY/news-headlines
546,SONN,Sonnet BioTherapeutics Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/SONN/news-headlines
547,SPPI,Spectrum Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SPPI/news-headlines
548,SPRB,Spruce Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/SPRB/news-headlines
549,SPRO,Spero Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SPRO/news-headlines
550,SRNE,Sorrento Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SRNE/news-headlines
551,SRPT,Sarepta Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SRPT/news-headlines
552,SRRA,Sierra Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/SRRA/news-headlines
553,SRRK,Scholar Rock Holding Corporation,https://www.nasdaq.com/market-activity/stocks/SRRK/news-headlines
554,STOK,Stoke Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/STOK/news-headlines
555,STRO,Sutro Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/STRO/news-headlines
556,STSA,Satsuma Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/STSA/news-headlines
557,STTK,Shattuck Labs Inc.,https://www.nasdaq.com/market-activity/stocks/STTK/news-headlines
558,SUPN,Supernus Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SUPN/news-headlines
559,SURF,Surface Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/SURF/news-headlines
560,SVA,Sinovac Biotech Ltd.,https://www.nasdaq.com/market-activity/stocks/SVA/news-headlines
561,SVRA,Savara Inc.,https://www.nasdaq.com/market-activity/stocks/SVRA/news-headlines
562,SWTX,SpringWorks Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SWTX/news-headlines
563,SYBX,Synlogic Inc.,https://www.nasdaq.com/market-activity/stocks/SYBX/news-headlines
564,SYN,Synthetic Biologics Inc.,https://www.nasdaq.com/market-activity/stocks/SYN/news-headlines
565,SYRS,Syros Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SYRS/news-headlines
566,TAK,Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of),https://www.nasdaq.com/market-activity/stocks/TAK/news-headlines
567,TARA,Protara Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TARA/news-headlines
568,TBIO,Translate Bio Inc.,https://www.nasdaq.com/market-activity/stocks/TBIO/news-headlines
569,TBPH,Theravance Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/TBPH/news-headlines
570,TCDA,Tricida Inc.,https://www.nasdaq.com/market-activity/stocks/TCDA/news-headlines
571,TCON,TRACON Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/TCON/news-headlines
572,TCRR,TCR2 Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TCRR/news-headlines
573,TENX,Tenax Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TENX/news-headlines
574,TEVA,Teva Pharmaceutical Industries Limited American Depositary Shares,https://www.nasdaq.com/market-activity/stocks/TEVA/news-headlines
575,TFFP,TFF Pharmaceuticals Inc - Ordinary Shares,https://www.nasdaq.com/market-activity/stocks/TFFP/news-headlines
576,TGTX,TG Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TGTX/news-headlines
577,TLC,Taiwan Liposome Company Ltd.,https://www.nasdaq.com/market-activity/stocks/TLC/news-headlines
578,TLSA,Tiziana Life Sciences plc,https://www.nasdaq.com/market-activity/stocks/TLSA/news-headlines
579,TMBR,Timber Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/TMBR/news-headlines
580,TNXP,Tonix Pharmaceuticals Holding Corp.,https://www.nasdaq.com/market-activity/stocks/TNXP/news-headlines
581,TOCA,Tocagen,https://www.nasdaq.com/market-activity/stocks/TOCA/news-headlines
582,TPTX,Turning Point Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TPTX/news-headlines
583,TRIL,Trillium Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TRIL/news-headlines
584,TRVI,Trevi Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TRVI/news-headlines
585,TRVN,Trevena Inc.,https://www.nasdaq.com/market-activity/stocks/TRVN/news-headlines
586,TTNP,Titan Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/TTNP/news-headlines
587,TXMD,TherapeuticsMD Inc.,https://www.nasdaq.com/market-activity/stocks/TXMD/news-headlines
588,TYME,Tyme Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/TYME/news-headlines
589,UBX,Unity Biotechnology Inc.,https://www.nasdaq.com/market-activity/stocks/UBX/news-headlines
590,URGN,UroGen Pharma Ltd.,https://www.nasdaq.com/market-activity/stocks/URGN/news-headlines
591,UROV,Urovant Sciences Ltd.,https://www.nasdaq.com/market-activity/stocks/UROV/news-headlines
592,UTHR,United Therapeutics Corporation,https://www.nasdaq.com/market-activity/stocks/UTHR/news-headlines
593,VBIV,VBI Vaccines Inc.,https://www.nasdaq.com/market-activity/stocks/VBIV/news-headlines
594,VBLT,Vascular Biogenics Ltd.,https://www.nasdaq.com/market-activity/stocks/VBLT/news-headlines
595,VCEL,Vericel Corporation,https://www.nasdaq.com/market-activity/stocks/VCEL/news-headlines
596,VCNX,Vaccinex Inc.,https://www.nasdaq.com/market-activity/stocks/VCNX/news-headlines
597,VERU,Veru Inc.,https://www.nasdaq.com/market-activity/stocks/VERU/news-headlines
598,VIE,Viela Bio Inc.,https://www.nasdaq.com/market-activity/stocks/VIE/news-headlines
599,VIR,Vir Biotechnology Inc.,https://www.nasdaq.com/market-activity/stocks/VIR/news-headlines
600,VKTX,Viking Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VKTX/news-headlines
601,VNDA,Vanda Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/VNDA/news-headlines
602,VRCA,Verrica Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/VRCA/news-headlines
603,VRNA,Verona Pharma plc,https://www.nasdaq.com/market-activity/stocks/VRNA/news-headlines
604,VRTX,Vertex Pharmaceuticals Incorporated,https://www.nasdaq.com/market-activity/stocks/VRTX/news-headlines
605,VSTM,Verastem Inc.,https://www.nasdaq.com/market-activity/stocks/VSTM/news-headlines
606,VTGN,VistaGen Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VTGN/news-headlines
607,VTVT,vTv Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VTVT/news-headlines
609,VXRT,Vaxart Inc.,https://www.nasdaq.com/market-activity/stocks/VXRT/news-headlines
610,VYGR,Voyager Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VYGR/news-headlines
611,WVE,Wave Life Sciences Ltd.,https://www.nasdaq.com/market-activity/stocks/WVE/news-headlines
612,XBIO,Xenetic Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/XBIO/news-headlines
613,XBIT,XBiotech Inc.,https://www.nasdaq.com/market-activity/stocks/XBIT/news-headlines
614,XENE,Xenon Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/XENE/news-headlines
615,XENT,Intersect ENT Inc.,https://www.nasdaq.com/market-activity/stocks/XENT/news-headlines
616,XERS,Xeris Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/XERS/news-headlines
617,XFOR,X4 Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/XFOR/news-headlines
618,XLRN,Acceleron Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/XLRN/news-headlines
619,XNCR,Xencor Inc.,https://www.nasdaq.com/market-activity/stocks/XNCR/news-headlines
620,XOMA,XOMA Corporation,https://www.nasdaq.com/market-activity/stocks/XOMA/news-headlines
621,XTLB,XTL Biopharmaceuticals Ltd.,https://www.nasdaq.com/market-activity/stocks/XTLB/news-headlines
622,XXII,22nd Century Group Inc.,https://www.nasdaq.com/market-activity/stocks/XXII/news-headlines
623,YMAB,Y-mAbs Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/YMAB/news-headlines
624,ZEAL,Zealand Pharma A/S,https://www.nasdaq.com/market-activity/stocks/ZEAL/news-headlines
625,ZGNX,Zogenix Inc.,https://www.nasdaq.com/market-activity/stocks/ZGNX/news-headlines
626,ZIOP,ZIOPHARM Oncology Inc,https://www.nasdaq.com/market-activity/stocks/ZIOP/news-headlines
627,ZLAB,Zai Lab Limited,https://www.nasdaq.com/market-activity/stocks/ZLAB/news-headlines
628,ZNTL,Zentalis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ZNTL/news-headlines
629,ZSAN,Zosano Pharma Corporation,https://www.nasdaq.com/market-activity/stocks/ZSAN/news-headlines
630,ZYME,Zymeworks Inc.,https://www.nasdaq.com/market-activity/stocks/ZYME/news-headlines
631,ZYNE,Zynerba Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ZYNE/news-headlines
